Cancer-related inflammation
Open accessThe DOI matches its Crossref record; 174 of the 175 references it cites were found in a registry or an index.
Abstract
The mediators and cellular effectors of inflammation are important constituents of the local environment of tumours. In some types of cancer, inflammatory conditions are present before a malignant change occurs. Conversely, in other types of cancer, an oncogenic change induces an inflammatory microenvironment that promotes the development of tumours. Regardless of its origin, 'smouldering' inflammation in the tumour microenvironment has many tumour-promoting effects. It aids in the proliferation and survival of malignant cells, promotes angiogenesis and metastasis, subverts adaptive immune responses, and alters responses to hormones and chemotherapeutic agents. The molecular pathways of this cancer-related inflammation are now being unravelled, resulting in the identification of new target molecules that could lead to improved diagnosis and treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“many of these processes also occur in cancer as most of them are inflammation-related, including hypoxia-induced neovascularization, endothelial dysfunction, permeability of the microvasculature and the upregulation of adhesion molecules to facilitate the recruitment of cells30,31.”
From Perspectives and opportunities for nanomedicine in the management of atherosclerosis (2011) · cites this paper as [31]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“On the other hand, cytokine production can be triggered by oncogenic transformation, metabolic alteration, cell death, hypoxia, and the use of anti-cancer drugs (10).”
From Tumor-Induced Inflammatory Cytokines and the Emerging Diagnostic Devices for Cancer Detection and Prognosis (2021) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Besides promoting cell proliferation, the action of cytokines in promoting cancer development includes antagonizing anti-tumor immune response, recruiting tumor-supportive stromal cells and immune-suppressive cells, inducing angiogenesis and metastasis, and altering the responses to therapeutic agents (10, 15)”
From Tumor-Induced Inflammatory Cytokines and the Emerging Diagnostic Devices for Cancer Detection and Prognosis (2021) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Excessive or dysregulated inflammation is a major driver of tissue damage and the pathogenesis of numerous diseases, including stroke, Parkinson’s disease, atherosclerosis, and cancer [9,30,31,32,33].”
From Picroside II as a Potential Anti-Inflammatory Agent (2026) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Therefore, rather than the dogma that oncogenesis is intrinsically triggered in pre-neoplastic cells, environmental factors, such as infection, stress, obesity, aging and smoking, each of which can induce chronic inflammation, could be a major cause of oncogenesis (4, 6, 9, 233).”
From IL-6 in inflammation, autoimmunity and cancer (2021) · cites this paper as [6]
Experimental — accuracy not yet measured
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746 · cited 1×
“jpg" NDATA ITEM> ]> Links between cancer and inflammation were first made in the nineteenth century, on the basis of observations that tumours often arose at sites of chronic inflammation and that inflammatory cells were present in biopsied samples from tumour”
Self-citationMANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528 · cited 1×
“TAMs and related cell types in mouse and human tumours generally have an M2 phenotype, which is oriented towards promoting tumour growth, remodelling tissues, promoting angiogenesis and suppressing adaptive immunity&hairsp”
Self-citationInvolvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
Nuclear factor-κB in cancer development and progression
Karin, M. (2006) · Nature · doi:10.1038/nature04870 · Cited by 3,519
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., MacDonald, D. D., Jin, D. K., Shido, K., Kerns, S. A., et al. (2005) · Nature · doi:10.1038/nature04186 · Cited by 3,288
Apetoh, L., Ghiringhelli, F., Tesniere, A., Obeid, M., Ortiz, C., Criollo, A., Mignot, G., Maiuri, M. C., Ullrich, E., Saulnier, P., et al. (2007) · Nature Medicine · doi:10.1038/nm1622 · Cited by 3,056 · cited 1×
“This type of response might also contribute to successful chemotherapy or radiotherapy, according to recent data obtained by Lionel Apetoh and colleague”
The Immunobiology of Cancer Immunosurveillance and Immunoediting
Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.017 · Cited by 3,032 · cited 1×
“Cancer-related inflammation and adaptive immunity There is strong evidence from genetic studies of mouse models that cells of the adaptive immune system carry out surveillance and can eliminate nascent tumours (a process called immuno-editing”
Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C., & Darnell, J. E. (1999) · Cell · doi:10.1016/s0092-8674(00)81959-5 · Cited by 2,790 · cited 1×
“This transcription factor is constitutively activated both in tumour cells and in immune cells, and is involved in oncogenesis and inhibition of apoptosi”
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
Condeelis, J., & Pollard, J. W. (2006) · Cell · doi:10.1016/j.cell.2006.01.007 · Cited by 2,695 · cited 1×
“TAMs have been described as “obligate partners for tumour-cell migration, invasion and metastasis&rdquo”
Cited by
Items 401–500 of 1,085
Glutathione peroxidases in different stages of carcinogenesis
Brigelius-Flohé, R., & Kipp, A. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.03.006 · Cited by 305
Stotz, M., Pichler, M., Absenger, G., Szkandera, J., Arminger, F., Schaberl-Moser, R., Samonigg, H., Stojakovic, T., & Gerger, A. (2014) · British Journal of Cancer · doi:10.1038/bjc.2013.785 · Cited by 310
“Another reason might be, that tumour-related leukocytes, especially monocytes, which are main regulators of cancer inflammation, have an essential role in systemic inflammatory response to tumorous disease (Allavena et al, 2008; Mantovani et al, 2008).”
BackgroundInfluentialHoyo, C., Cook, M. B., Kamangar, F., Freedman, N. D., Whiteman, D. C., Bernstein, L., Brown, L. M., Risch, H. A., Ye, W., Sharp, L., et al. (2012) · International Journal of Epidemiology · doi:10.1093/ije/dys176 · Cited by 300
Role of nonresolving inflammation in hepatocellular carcinoma development and progression
Yu, L.-X., Ling, Y., & Wang, H.-Y. (2018) · npj Precision Oncology · doi:10.1038/s41698-018-0048-z · Cited by 301
“Two distinct pathways that causing nonresolving inflammation during cancer development have been described.(19) In the extrinsic pathway, exogenous factors (e.”
BackgroundMechanisms of tumor cell extravasation in an in vitro microvascular network platform
Chen, M. B., Whisler, J. A., Jeon, J. S., & Kamm, R. D. (2013) · Integrative Biology · doi:10.1039/c3ib40149a · Cited by 308
Designing a broad-spectrum integrative approach for cancer prevention and treatment
Block, K. I., Gyllenhaal, C., Lowe, L., Amedei, A., Amin, A. R. M. R., Amin, A., Aquilano, K., Arbiser, J., Arreola, A., Arzumanyan, A., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.09.007 · Cited by 300
“[122] Mantovani A, Allavena P, Sica A, Balkwill F.”
BackgroundAn Attempt to Polarize Human Neutrophils Toward N1 and N2 Phenotypes in vitro
Ohms, M., Möller, S., & Laskay, T. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00532 · Cited by 299
Polarization dictates iron handling by inflammatory and alternatively activated macrophages
Corna, G., Campana, L., Pignatti, E., Castiglioni, A., Tagliafico, E., Bosurgi, L., Campanella, A., Brunelli, S., Manfredi, A. A., Apostoli, P., et al. (2010) · Haematologica · doi:10.3324/haematol.2010.023879 · Cited by 304
“M2 cells play a pivotal role in sustaining angiogenesis, wound repair and tumor growth.(41,42) These functions are associated with their ability to provide nutrients, including iron, to the healing tissues.”
BackgroundMantovani, A., & Locati, M. (2013) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.113.300168 · Cited by 290
Self-citationJensen, T. O., Schmidt, H., Møller, H. J., Donskov, F., Høyer, M., Sjoegren, P., Christensen, I. J., & Steiniche, T. (2012) · Cancer · doi:10.1002/cncr.26511 · Cited by 281
Hunter, P. (2012) · EMBO reports · doi:10.1038/embor.2012.142 · Cited by 292
“Indeed, a study from the Istituto Clinico Humanitas in Milan, Italy, suggests that an inflammatory microenvironment is essential for all cancers [3], although the causal mechanisms have yet to be established.”
Labi, V, & Erlacher, M. (2015) · Cell Death & Disease · doi:10.1038/cddis.2015.20 · Cited by 295
“Dying cells activate macrophages, dendritic cells, neutrophils andmast cells that secretemitogenic cytokines such as IL1, IL6 or TNFα.95 Thus, next to their major function of immune surveillance,96 the immune and inflammatory systems also foster malignant transformation under certain circumstances.95 In sum, we propos…”
BackgroundInfluentialBulla, R., Tripodo, C., Rami, D., Ling, G. S., Agostinis, C., Guarnotta, C., Zorzet, S., Durigutto, P., Botto, M., & Tedesco, F. (2016) · Nature Communications · doi:10.1038/ncomms10346 · Cited by 294
Colorectal liver metastasis: molecular mechanism and interventional therapy
Zhou, H., Liu, Z., Wang, Y., Wen, X., Amador, E. H., Yuan, L., Ran, X., Xiong, L., Ran, Y., Chen, W., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00922-2 · Cited by 298
“Immune cells Immune microenvironment plays a pivotal role in CRLM.(33) The liver is an important immune organ of the human body.”
BackgroundHerrera, M., Herrera, A., Domínguez, G., Silva, J., García, V., García, J. M., Gómez, I., Soldevilla, B., Muñoz, C., Provencio, M., et al. (2013) · Cancer Science · doi:10.1111/cas.12096 · Cited by 289
Fest, J., Ruiter, R., Ikram, M. A., Voortman, T., van Eijck, C. H. J., & Stricker, B. H. (2018) · Scientific Reports · doi:10.1038/s41598-018-28646-w · Cited by 297
Induction of autophagy is essential for monocyte-macrophage differentiation
Zhang, Y., Morgan, M. J., Chen, K., Choksi, S., & Liu, Z.-G. (2012) · Blood · doi:10.1182/blood-2011-08-372383 · Cited by 291
Autophagy and disease: always two sides to a problem
Sridhar, S., Botbol, Y., Macian, F., & Cuervo, A. M. (2012) · The Journal of Pathology · doi:10.1002/path.3025 · Cited by 293
Schwitalla, S., Ziegler, P. K., Horst, D., Becker, V., Kerle, I., Begus-Nahrmann, Y., Lechel, A., Rudolph, K. L., Langer, R., Slotta-Huspenina, J., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2012.11.014 · Cited by 296
Trellakis, S., Bruderek, K., Dumitru, C. A., Gholaman, H., Gu, X., Bankfalvi, A., Scherag, A., Hütte, J., Dominas, N., Lehnerdt, G. F., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.25892 · Cited by 281
Veltman, J. D., Lambers, M. E., van Nimwegen, M., Hendriks, R. W., Hoogsteden, H. C., Aerts, J. G., & Hegmans, J. P. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-464 · Cited by 291
“Increased evidence indicates that immune suppressive cells, recruited by tumour-derived factors, are the main cause of failure of novel anti-cancer therapies, including immunotherapy [4,19-24].”
BackgroundKinoshita, A., Onoda, H., Imai, N., Iwaku, A., Oishi, M., Fushiya, N., Koike, K., Nishino, H., & Tajiri, H. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.354 · Cited by 293
“The host inflammatory response has an important role in the development and progression of cancer (Mantovani et al, 2008).”
Background(1926) · The American Journal of Surgery · doi:10.1016/s0002-9610(26)90068-8 · Cited by 293
Macrophages, Inflammation, and Lung Cancer
Conway, E. M., Pikor, L. A., Kung, S. H. Y., Hamilton, M. J., Lam, S., Lam, W. L., & Bennewith, K. L. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201508-1545ci · Cited by 286
MicroRNAs in resolution of acute inflammation: identification of novel resolvin Dl‐miRNA circuits
Recchiuti, A., Krishnamoorthy, S., Fredman, G., Chiang, N., & Serhan, C. N. (2011) · The FASEB Journal · doi:10.1096/fj.10-169599 · Cited by 292
“mation, cancer (10), and atherosclerosis (11).”
Karnezis, T., Shayan, R., Caesar, C., Roufail, S., Harris, N. C., Ardipradja, K., Zhang, Y. F., Williams, S. P., Farnsworth, R. H., Chai, M. G., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2011.12.026 · Cited by 281
“These studies found that VEGF-D regulates the structure of the tumor-draining CLVs through a PG-dependent mechanism, consistent with the elevated levels of inflammatory mediators, such as PGs (Mantovani et al., 2008).”
BackgroundObesity and Cancer: Local and Systemic Mechanisms
Iyengar, N. M., Hudis, C. A., & Dannenberg, A. J. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-050913-022228 · Cited by 281
“The microenvironment of tumors has been described to closely resemble that of wounds, including an influx of activated immune cells with local production of proinflammatory mediators (77).”
BackgroundThe evolution of the cancer niche during multistage carcinogenesis
Barcellos-Hoff, M. H., Lyden, D., & Wang, T. C. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3536 · Cited by 279
Cedrés, S., Torrejon, D., Martínez, A., Martinez, P., Navarro, A., Zamora, E., Mulet-Margalef, N., & Felip, E. (2012) · Clinical and Translational Oncology · doi:10.1007/s12094-012-0872-5 · Cited by 293
“Inflammation seems to play a critical role in the development and progression of numerous cancers by promoting cancer cell proliferation and survival, angiogenesis, tumor metastasis and impacting tumor response to systemic therapies [4].”
BackgroundBeyond proteases: Basement membrane mechanics and cancer invasion
Chang, J., & Chaudhuri, O. (2019) · Journal of Cell Biology · doi:10.1083/jcb.201903066 · Cited by 280
“Laminin, the most abundant component of the BM, is a biologically active glycoprotein heterotrimer formed by one α, one β, and one γ chain (Martin and Timpl, 1987); there have been five α, four β, and three γ subunits and at least 16 laminin isoforms identified (Yurchenco, 2011).”
BackgroundBai, R., Li, Y., Jian, L., Yang, Y., Zhao, L., & Wei, M. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01645-2 · Cited by 279
O'Brien, J., Lyons, T., Monks, J., Lucia, M. S., Wilson, R. S., Hines, L., Man, Y.-G., Borges, V., & Schedin, P. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090735 · Cited by 288
Eosinophils: The unsung heroes in cancer?
Varricchi, G., Galdiero, M. R., Loffredo, S., Lucarini, V., Marone, G., Mattei, F., Marone, G., & Schiavoni, G. (2018) · OncoImmunology · doi:10.1080/2162402x.2017.1393134 · Cited by 280
Activating Macrophage‐Mediated Cancer Immunotherapy by Genetically Edited Nanoparticles
Rao, L., Zhao, S., Wen, C., Tian, R., Lin, L., Cai, B., Sun, Y., Kang, F., Yang, Z., He, L., et al. (2020) · Advanced Materials · doi:10.1002/adma.202004853 · Cited by 279
Single tumor-initiating cells evade immune clearance by recruiting type II macrophages
Guo, X., Zhao, Y., Yan, H., Yang, Y., Shen, S., Dai, X., Ji, X., Ji, F., Gong, X.-G., Li, L., et al. (2017) · Genes & Development · doi:10.1101/gad.294348.116 · Cited by 285
Krenn-Pilko, S., Langsenlehner, U., Thurner, E.-M., Stojakovic, T., Pichler, M., Gerger, A., Kapp, K. S., & Langsenlehner, T. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.163 · Cited by 281
“…measured by surrogate blood-based parameters, such as C-reactive protein, neutrophil, or platelet count, has an important role in the progression of several solid tumours (Coussens and Werb, 2002; Mantovani et al, 2008; Roxburgh and McMillan, 2012; Dethlefsen et al, 2013; Szkandera et al, 2013).”
BackgroundZhang, B., Wang, Z., Wu, L., Zhang, M., Li, W., Ding, J., Zhu, J., Wei, H., & Zhao, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057114 · Cited by 269
Crosstalk of Inflammatory Cytokines within the Breast Tumor Microenvironment
Habanjar, O., Bingula, R., Decombat, C., Diab-Assaf, M., Caldefie-Chezet, F., & Delort, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044002 · Cited by 263
“Therefore, blocking TNFα or its receptors may have significant anti-tumor effects [31,243,244] and inhibition of TNFα on tumorigenesis can be positive depending on the immune microenvironment and TNFα concentration.”
BackgroundWeber, C. E., & Kuo, P. C. (2012) · Surgical Oncology · doi:10.1016/j.suronc.2011.09.001 · Cited by 271
“The major leukocytes that have been identified as vital to this interaction or progression of inflammation to cancer are termed TAMs- tumor associated macrophages [37].”
BackgroundMao, Y., Sarhan, D., Steven, A., Seliger, B., Kiessling, R., & Lundqvist, A. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0635 · Cited by 274
“cells, have been reported to be expanded in tumor-bearing animals and patients with cancer (1).”
BackgroundMetabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer
Liu, S., Zhang, X., Wang, W., Li, X., Sun, X., Zhao, Y., Wang, Q., Li, Y., Hu, F., & Ren, H. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02165-x · Cited by 246
Topography of cancer-associated immune cells in human solid tumors
Kather, J. N., Suarez-Carmona, M., Charoentong, P., Weis, C.-A., Hirsch, D., Bankhead, P., Horning, M., Ferber, D., Kel, I., Herpel, E., et al. (2018) · eLife · doi:10.7554/elife.36967 · Cited by 280
Fu, Q., Chen, N., Ge, C., Li, R., Li, Z., Zeng, B., Li, C., Wang, Y., Xue, Y., Song, X., et al. (2019) · OncoImmunology · doi:10.1080/2162402x.2019.1593806 · Cited by 274
Korniluk, A., Koper, O., Kemona, H., & Dymicka-Piekarska, V. (2017) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-016-1464-0 · Cited by 282
NOD-Like Receptors: Master Regulators of Inflammation and Cancer
Saxena, M., & Yeretssian, G. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00327 · Cited by 274
“While some cancers arise from chronic inflammation or after immune deregulation and autoimmunity, solid malignancies elicit intrinsic immune mechanisms that guide the construction of a tumorigenic microenvironment (12, 13, 20).”
BackgroundExercise and the aging immune system
Simpson, R. J., Lowder, T. W., Spielmann, G., Bigley, A. B., LaVoy, E. C., & Kunz, H. (2012) · Ageing Research Reviews · doi:10.1016/j.arr.2012.03.003 · Cited by 281
“, 2008), osteoporosis (Lencel and Magne, 2011) and certain cancers (Allavena et al., 2008; Mantovani et al., 2008).”
Sensing damage by the NLRP3 inflammasome
Leemans, J. C., Cassel, S. L., & Sutterwala, F. S. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01043.x · Cited by 281
“However, one must bear in mind when treating cancer patients with IL-1b blockers that inflammation has both tumor-suppressive and tumor-promoting functions (97).”
NFκB signaling in carcinogenesis and as a potential molecular target for cancer therapy
Shen, H.-M., & Tergaonkar, V. (2009) · Apoptosis · doi:10.1007/s10495-009-0315-0 · Cited by 275
Srikrishna, G., & Freeze, H. H. (2009) · Neoplasia · doi:10.1593/neo.09284 · Cited by 275
“Emerging information points to two different pathways linking the pathologies [3]: an extrinsic pathway mediated by chronic inflammation that increases the risk of tumorigenesis (inflammationinduced cancer) and an intrinsic pathway in which genetic alterations, in the absence of an underlying inflammation, initiate a…”
BackgroundDiabetes and cancer: two diseases with obesity as a common risk factor
Garg, S. K., Maurer, H., Reed, K., & Selagamsetty, R. (2014) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12124 · Cited by 275
“Diabetes is usually associated with a low-grade pro-inflammatory state, and this could be a key factor in encouraging tumorigenesis [91].”
BackgroundOkugawa, Y., Toiyama, Y., Yamamoto, A., Shigemori, T., Ide, S., Kitajima, T., Fujikawa, H., Yasuda, H., Hiro, J., Yoshiyama, S., et al. (2020) · Annals of Surgery · doi:10.1097/sla.0000000000003239 · Cited by 280
Using the molecular classification of glioblastoma to inform personalized treatment
Olar, A., & Aldape, K. D. (2014) · The Journal of Pathology · doi:10.1002/path.4282 · Cited by 261
Heat shock proteins and heat shock factor 1 in carcinogenesis and tumor development: an update
Ciocca, D. R., Arrigo, A. P., & Calderwood, S. K. (2013) · Archives of Toxicology · doi:10.1007/s00204-012-0918-z · Cited by 265
“Most tumors appear to be immunosuppressive in nature due to a range of mechanisms including release of the immunosuppressive cytokine interleukin-10 and activation of regulatory T lymphocytes and myeloidderived suppressor cells (MDSC) (Pekarek et al. 1995; Mantovani et al. 2008; Marigo et al. 2008).”
Dual Role of GM-CSF as a Pro-Inflammatory and a Regulatory Cytokine: Implications for Immune Therapy
Bhattacharya, P., Budnick, I., Singh, M., Thiruppathi, M., Alharshawi, K., Elshabrawy, H., Holterman, M. J., & Prabhakar, B. S. (2015) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2014.0149 · Cited by 264
“Since cytokines play a major role in modulating antitumor immune response (Candido and Hagemann 2013), cytokines such as IL-2 (Forni and others 1985; Forni and others 1988) and GM-CSF (Dranoff 2002, 2003) have been used in cancer treatment protocols for eliciting a strong antitumor immune response.”
MethodPotential role of bromelain in clinical and therapeutic applications
Rathnavelu, V., Alitheen, N. B., Sohila, S., Kanagesan, S., & Ramesh, R. (2016) · Biomedical Reports · doi:10.3892/br.2016.720 · Cited by 261
“In addition, bromelain decreases the activity of cell survival regulators, such as Akt and extra-cellular signal-regulated kinases, thus promoting apoptotic cell death in tumors (46).”
BackgroundHow platelets safeguard vascular integrity
HO‐TIN‐NOÉ, B., DEMERS, M., & WAGNER, D. D. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04317.x · Cited by 271
Tili, E., Michaille, J.-J., Adair, B., Alder, H., Limagne, E., Taccioli, C., Ferracin, M., Delmas, D., Latruffe, N., & Croce, C. M. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq143 · Cited by 273
Liu, Y., Yan, W., Tohme, S., Chen, M., Fu, Y., Tian, D., Lotze, M., Tang, D., & Tsung, A. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.009 · Cited by 267
“Significant evidence links cancer development and progression to the continuous oxidative stress and chronic inflammation found in the tumor microenvironment [3].”
BackgroundLalani, A.-K. A., Xie, W., Martini, D. J., Steinharter, J. A., Norton, C. K., Krajewski, K. M., Duquette, A., Bossé, D., Bellmunt, J., Van Allen, E. M., et al. (2018) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0315-0 · Cited by 270
“The neutrophil count is thought to reflect the inflammatory microenvironment that in turn has tumor-promoting activity, including cancer cell survival and proliferation, angiogenesis and metastasis, as well as subversion of adaptive immune responses [26].”
BackgroundThe microbiota and microbiome in pancreatic cancer: more influential than expected
Wei, M.-Y., Shi, S., Liang, C., Meng, Q.-C., Hua, J., Zhang, Y.-Y., Liu, J., Zhang, B., Xu, J., & Yu, X.-J. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1008-0 · Cited by 268
Cancer Inflammation and Cytokines
Galdiero, M. R., Marone, G., & Mantovani, A. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028662 · Cited by 267
“Tumor-related inflammatory responses vary depending on the context but, in general, tend to promote tumor progression (Mantovani et al. 2008; Galdiero et al. 2013b; Varricchi et al. 2017).”
BackgroundSelf-citationMAPK signaling in inflammation-associated cancer development
Huang, P., Han, J., & Hui, L. (2010) · Protein & Cell · doi:10.1007/s13238-010-0019-9 · Cited by 273
Does the Immune System Naturally Protect Against Cancer?
Corthay, A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00197 · Cited by 261
“In fact, an opposite and very influential concept was proposed in 2001 by Frances Balkwill and Alberto Mantovani, who suggested that inflammatory immune cells and cytokines found in tumors may promote rather than suppress tumor growth (9, 10).”
BackgroundThe cancer stem cell niche—there goes the neighborhood?
Cabarcas, S. M., Mathews, L. A., & Farrar, W. L. (2011) · International Journal of Cancer · doi:10.1002/ijc.26312 · Cited by 265
“triggered by chronic inflammation and it has been linked to the proliferation and metastasis of tumors.(46) The most com-”
BackgroundMunn, L. L. (2017) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1370 · Cited by 257
Metabolic reprogramming of macrophages during infections and cancer
Wang, S., Liu, R., Yu, Q., Dong, L., Bi, Y., & Liu, G. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.03.015 · Cited by 272
Microenvironment and tumor cell plasticity: An easy way out
Taddei, M. L., Giannoni, E., Comito, G., & Chiarugi, P. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.01.042 · Cited by 264
“Many observations indicate that CAMs show an M2 phenotype and this preferential polarization is caused by absence of M1-directing signals such as IFN-c or LPS as well as by expression of M2- stimuli [257,265,266].”
BackgroundThe Mitochondrial Chaperone TRAP1 Promotes Neoplastic Growth by Inhibiting Succinate Dehydrogenase
Sciacovelli, M., Guzzo, G., Morello, V., Frezza, C., Zheng, L., Nannini, N., Calabrese, F., Laudiero, G., Esposito, F., Landriscina, M., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.04.019 · Cited by 264
Epithelial-Mesenchymal Transition in tumor microenvironment
Jing, Y., Han, Z., Zhang, S., Liu, Y., & Wei, L. (2011) · Cell & Bioscience · doi:10.1186/2045-3701-1-29 · Cited by 270
“The inflammatory component is an essential part of the malignant microenvironment [8].”
BackgroundMolecular mechanisms of perineural invasion, a forgotten pathway of dissemination and metastasis
Marchesi, F., Piemonti, L., Mantovani, A., & Allavena, P. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.11.001 · Cited by 260
“Cytokines and chemokines are key components and orchestrators of the inflammatory milieu of tumors, enhancing cancer cell migration and survival in a distant microenvironment [4–7].”
BackgroundSelf-citationTumor Promotion via Injury- and Death-Induced Inflammation
Kuraishy, A., Karin, M., & Grivennikov, S. I. (2011) · Immunity · doi:10.1016/j.immuni.2011.09.006 · Cited by 261
“As far back as 1863, Rudolf Virchow hypothesized that previous tissue injury is required for tumor emergence (Mantovani et al., 2008).”
BackgroundXu, P., & Derynck, R. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.01.034 · Cited by 257
“Chronic inflammation due to infection or irritation enhances initiation of tumor development (Mantovani et al., 2008).”
InfluentialIron as a central player and promising target in cancer progression
Jung, M., Mertens, C., Tomat, E., & Brüne, B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020273 · Cited by 268
Antitumor and Anti-inflammatory Effects of Trabectedin on Human Myxoid Liposarcoma Cells
Germano, G., Frapolli, R., Simone, M., Tavecchio, M., Erba, E., Pesce, S., Pasqualini, F., Grosso, F., Sanfilippo, R., Casali, P. G., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2335 · Cited by 267
Self-citationKuang, D.-M., Peng, C., Zhao, Q., Wu, Y., Chen, M.-S., & Zheng, L. (2010) · Hepatology · doi:10.1002/hep.23291 · Cited by 263
Inflammation and Cancer: Causes and Consequences
Moore, M. M., Chua, W., Charles, K. A., & Clarke, S. J. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.254 · Cited by 258
Feng, J.-F., Huang, Y., & Chen, Q.-X. (2014) · World Journal of Surgical Oncology · doi:10.1186/1477-7819-12-58 · Cited by 267
“There is a strong linkage between inflammation and cancer [7,8].”
Backgroundde Lima, R. M. T., dos Reis, A. C., de Menezes, A. P. M., Santos, J. V. D. O., Filho, J. W. G. D. O., Ferreira, J. R. D. O., de Alencar, M. V. O. B., da Mata, A. M. O. F., Khan, I. N., Islam, A., et al. (2018) · Phytotherapy Research · doi:10.1002/ptr.6134 · Cited by 256
Helm, O., Held‐Feindt, J., Grage‐Griebenow, E., Reiling, N., Ungefroren, H., Vogel, I., Krüger, U., Becker, T., Ebsen, M., Röcken, C., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.28736 · Cited by 260
Resolvins suppress tumor growth and enhance cancer therapy
Sulciner, M. L., Serhan, C. N., Gilligan, M. M., Mudge, D. K., Chang, J., Gartung, A., Lehner, K. A., Bielenberg, D. R., Schmidt, B., Dalli, J., et al. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20170681 · Cited by 256
“chemotherapy-generated debris stimulates primary tumor growth via proinflammatory cytokines To further evaluate the potential mechanism or mechanisms by which drug-generated debris stimulates tumor growth, we next measured the extent to which debris promotes an inflammatory infiltrate, which is known to propagate tumo…”
BackgroundInfluentialCancer Stem Cell-Specific Scavenger Receptor CD36 Drives Glioblastoma Progression
Hale, J. S., Otvos, B., Sinyuk, M., Alvarado, A. G., Hitomi, M., Stoltz, K., Wu, Q., Flavahan, W., Levison, B., Johansen, M. L., et al. (2014) · Stem Cells · doi:10.1002/stem.1716 · Cited by 258
“In contrast to the normal brain, GBM contains regions of increased necrosis and apoptosis leading to the release of cellular debris [16] and activation of numerous inflammatory pathways [17].”
BackgroundTelomerase: central regulator of all of the hallmarks of cancer
Low, K. C., & Tergaonkar, V. (2013) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2013.07.001 · Cited by 257
Hu, Y., Chen, J., Hu, G., Yu, J., Zhu, X., Lin, Y., Chen, S., & Yuan, J. (2015) · Marine Drugs · doi:10.3390/md13010202 · Cited by 260
“We did not include an anti-inflammatory group, because inflammation underlies many diseases including cancer and neurological damage, such as Alzheimer’s disease [117,118].”
BackgroundBioactive Compounds Isolated from Microalgae in Chronic Inflammation and Cancer
Talero, E., García-Mauriño, S., Ávila-Román, J., Rodríguez-Luna, A., Alcaide, A., & Motilva, V. (2015) · Marine Drugs · doi:10.3390/md13106152 · Cited by 255
“and surface adhesion molecules, as well as the synthesis of COX-2 or iNOS [280].”
BackgroundImpact of cellular senescence signature on ageing research
Sikora, E., Arendt, T., Bennett, M., & Narita, M. (2011) · Ageing Research Reviews · doi:10.1016/j.arr.2010.10.002 · Cited by 264
Oxidatively induced DNA damage and its repair in cancer
Dizdaroglu, M. (2015) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2014.11.002 · Cited by 254
Fujimoto, H., Sangai, T., Ishii, G., Ikehara, A., Nagashima, T., Miyazaki, M., & Ochiai, A. (2009) · International Journal of Cancer · doi:10.1002/ijc.24378 · Cited by 263
“tions between tumor and stromal cells create a unique microenvironment which is essential for tumor progression.(1,2)”
BackgroundThe Inflammation and Liver Cancer
Bishayee, A. (2014) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-0348-0837-8_16 · Cited by 255
Regulation of Mast Cell Responses in Health and Disease
Gilfillan, A. M., & Beaven, M. A. (2011) · Critical Reviews™ in Immunology · doi:10.1615/critrevimmunol.v31.i6.30 · Cited by 259
Current and emerging concepts in tumour metastasis
Coghlin, C., & Murray, G. I. (2010) · The Journal of Pathology · doi:10.1002/path.2727 · Cited by 257
Modulation of Inflammatory Genes by Natural Dietary Bioactive Compounds
Pan, M.-H., Lai, C.-S., Dushenkov, S., & Ho, C.-T. (2009) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf900612n · Cited by 261
Cellular and molecular pathways linking inflammation and cancer
Porta, C., Larghi, P., Rimoldi, M., Grazia Totaro, M., Allavena, P., Mantovani, A., & Sica, A. (2009) · Immunobiology · doi:10.1016/j.imbio.2009.06.014 · Cited by 250
“inflammatory bowel disease) and an intrinsic pathway driven by genetic alterations that cause both inflammation and neoplasia (Mantovani et al. 2008).”
InfluentialSelf-citationHATAKEYAMA, M. (2017) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.93.013 · Cited by 261
Gender Disparity of Hepatocellular Carcinoma: The Roles of Sex Hormones
Yeh, S.-H., & Chen, P.-J. (2010) · Oncology · doi:10.1159/000315247 · Cited by 256
Differentiation and gene expression profile of tumor-associated macrophages
Schmieder, A., Michel, J., Schönhaar, K., Goerdt, S., & Schledzewski, K. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.02.002 · Cited by 255
Chae, Y. K., Chang, S., Ko, T., Anker, J., Agte, S., Iams, W., Choi, W. M., Lee, K., & Cruz, M. (2018) · Scientific Reports · doi:10.1038/s41598-018-21061-1 · Cited by 253
Lymphocytes in cancer development: Polarization towards pro-tumor immunity
Ruffell, B., DeNardo, D. G., Affara, N. I., & Coussens, L. M. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.11.002 · Cited by 253
“suppressive activity, and Tie2-expressing monocytes [3,4].”
Penny, H. L., Sieow, J. L., Adriani, G., Yeap, W. H., See Chi Ee, P., San Luis, B., Lee, B., Lee, T., Mak, S. Y., Ho, Y. S., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1191731 · Cited by 254
Xiao, M., Zhang, J., Chen, W., & Chen, W. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0815-2 · Cited by 256
Heme oxygenase-1 in tumor biology and therapy
Was, H., Dulak, J., & Jozkowicz, A. (2010) · Current Drug Targets · doi:10.2174/1389450111009011551 · Cited by 259
“[10] Mantovani A, Allavena P, Sica A, Balkwill F.”
Background
Metadata
- Authors
- Mantovani, A., Allavena, P., Sica, A., & Balkwill, F.
- Affiliations
- IRCCS Humanitas Research Hospital (IT)
- Fondazione Humanitas per la Ricerca (IT)
- Queen Mary University of London (GB)
- Venue
- Nature
- Published
- 2008-07-01
- Volume
- 454
- Issue
- 7203
- Pages
- 436-444
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2123105952
- Semantic Scholar
- b3a9e344a32ad6ca402d9149ac74b2b1df9e3076
- Cited by
- 11,399
- References
- 175
- Citations by year
- 2026: 419 · 2025: 554 · 2024: 655 · 2023: 761 · 2022: 848 · 2021: 878 · 2020: 864 · 2019: 759 · 2018: 752 · 2017: 732 · 2016: 692 · 2015: 683 · 2014: 643 · 2013: 574 · 2012: 510
- FWCI
- 26.32
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- other-oa
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- Funders
- Cancer Research UK
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
- Keywords
- tumor inflammation, tumor microenvironment, inflammatory mediators, angiogenesis, metastasis, immune evasion, chemoresistance, endocrine response, inflammatory signaling, therapeutic target
- MeSH terms
- Humans, Inflammation, Leukocytes, Neoplasm Invasiveness, Neoplasms, Oncogenes, Gonadal Steroid Hormones
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.